Alexey S. Revenko
Ionis Pharmaceuticals (United States)
ORCID: 0000-0002-4863-362XPilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 8 papers. Top paper: “Antisense oligonucleotide targeting of thrombopoietin represents a novel platelet depletion method to assess the immunomodulatory role of platelets”.
Benjamin G. Wu, Alexey S. Revenko, A. Robert MacLeod, Leopoldo N. Segal, Jeffrey S. Berger +1 more
Hampartsoum B. Barsoumian, Nahum Puebla‐Osorio, Yun Hu, Duygu Sezen, Mark Wasley +16 more
Kazumi Eckenstein, Alexey S. Revenko, Brooke A. Anderson, W Brad Wan, Alison N. McCracken +6 more
Denise Ng, David Requena, Caroline S. Jiang, Adam Qureshi, Roger Vaughan +4 more
Yi Yang, Ananya Dutta, Michelle Luo, Zimu Wei, Sara R. Abrahams +10 more
Naly Setthavongsack, Anh Le-Cook, Andy Kaempf, Jennifer M. Loftis, R. L. Woltjer +5 more
H. Alex Feldman, Leah Rosenfeldt, Ayad Ali, Benjamin Gourley, Cassandra Sprague +7 more
Namit Padgaonkar, Kelly Crumley, Eiji Saito, Zoe Beekman, Alexa DeKorte +4 more